Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
LOW
|
Maureen K Ausura
EVP Human Resources |
SELL
Open market or private sale
|
Direct | 146,233 Reduced 64.57% |
$7,264,855
$49.68 p/Share
|
Apr 02
2014 |
COST
|
Franz E Lazarus
Executive VP |
SELL
Open market or private sale
|
Indirect | 600 Reduced 2.18% |
$67,296
$112.16 p/Share
|
Apr 01
2014 |
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Open market or private sale
|
Indirect | 219 Reduced 0.2% |
$4,054
$18.51 p/Share
|
Apr 01
2014 |
ORCL
|
Mark V Hurd
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 500,000 Reduced 99.8% |
$20,790,001
$41.58 p/Share
|
Apr 01
2014 |
ADBE
|
Mark Garrett
EVP, CFO & Asst. Secretary |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 85.7% |
$990,300
$66.02 p/Share
|
Apr 01
2014 |
ADBE
|
Shantanu Narayen
Chair and CEO |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 16.2% |
$3,300,000
$66.0 p/Share
|
Apr 01
2014 |
ADBE
|
Charles M Geschke
Director |
SELL
Open market or private sale
|
Indirect | 33,500 Reduced 10.96% |
$2,205,305
$65.83 p/Share
|
Apr 01
2014 |
NKE
|
John C Lechleiter
Director |
BUY
Open market or private purchase
|
Direct | 750 Added 9.09% |
$55,748
$74.33 p/Share
|
Apr 01
2014 |
AMT
|
Edmund Di Santo |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 43.09% |
$4,080,000
$81.6 p/Share
|
Apr 01
2014 |
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,456 Reduced 9.36% |
$259,200
$75.0 p/Share
|
Mar 31
2014 |
FDX
|
John L Merino
CVP PRIN ACCT OFFICER |
SELL
Open market or private sale
|
Direct | 18,210 Reduced 44.49% |
$2,406,634
$132.16 p/Share
|
Mar 31
2014 |
ORCL
|
W Corey West
Controller, EVP, CAO |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 90.91% |
$2,051,500
$41.03 p/Share
|
Mar 31
2014 |
ADBE
|
David Wadhwani
President, Digital Media |
SELL
Open market or private sale
|
Direct | 17,288 Reduced 40.88% |
$1,136,513
$65.74 p/Share
|
Mar 31
2014 |
HOFD
|
Jefferies Financial Group Inc. |
BUY
Open market or private purchase
|
Direct | 6,986,337 Added 42.48% |
-
|
Mar 28
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 306,945 Added 0.1% |
$94,468,459
$307.77 p/Share
|
Mar 28
2014 |
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 15,411 Reduced 29.45% |
$1,143,188
$74.18 p/Share
|
Mar 28
2014 |
AAPL
|
Daniel J. Riccio
Senior Vice President |
SELL
Open market or private sale
|
Direct | 3,064 Reduced 100.0% |
$1,648,800
$538.12 p/Share
|
Mar 27
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 306,945 Added 0.12% |
$95,300,287
$310.48 p/Share
|
Mar 27
2014 |
NEM
|
Chris J Robison
EVP, COO |
BUY
Open market or private purchase
|
Direct | 4,494 Added 15.5% |
$105,924
$23.57 p/Share
|
Mar 26
2014 |
ORCL
|
Dorian Daley
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 95.24% |
$3,827,000
$38.27 p/Share
|
Mar 25
2014 |
JEF
|
Stuart Harry Reese |
BUY
Open market or private purchase
|
Direct | 4,000 Added 50.0% |
$108,440
$27.11 p/Share
|
Mar 25
2014 |
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Open market or private sale
|
Indirect | 2,445 Reduced 2.16% |
$45,232
$18.5 p/Share
|
Mar 25
2014 |
ALNY
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 344,448 Added 3.64% |
$23,036,681
$66.88 p/Share
|
Mar 25
2014 |
ADBE
|
John E Warnock
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 75.66% |
$3,281,000
$65.62 p/Share
|
Mar 24
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 306,945 Added 0.1% |
$94,140,035
$306.7 p/Share
|
Mar 24
2014 |
ORCL
|
Jeffrey Henley
Vice Chairman |
SELL
Open market or private sale
|
Direct | 750,000 Reduced 100.0% |
$28,694,999
$38.26 p/Share
|
Mar 21
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 305,115 Added 0.08% |
$98,472,812
$322.74 p/Share
|
Mar 21
2014 |
NVDA
|
Ajay K Puri
EVP, Worldwide Field Ops |
BUY
Open market or private purchase
|
Direct | 114 Added 0.02% |
$2,147
$18.83 p/Share
|
Mar 21
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 57,957 Added 0.08% |
$18,993,668
$327.72 p/Share
|
Mar 20
2014 |
NVDA
|
Debora Shoquist
EVP, Operations |
SELL
Open market or private sale
|
Direct | 8,085 Reduced 4.16% |
$149,815
$18.53 p/Share
|
Mar 20
2014 |
ADBE
|
James E Daley
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 24.89% |
$345,000
$69.0 p/Share
|
Mar 20
2014 |
SPOK
|
Matthew Oristano
Director |
SELL
Open market or private sale
|
Direct | 2,476 Reduced 15.4% |
$42,067
$16.99 p/Share
|
Mar 19
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 9,746 Added 0.02% |
$3,192,497
$327.57 p/Share
|
Mar 19
2014 |
LOW
|
Robert A Niblock
Chairman President & CEO |
SELL
Open market or private sale
|
Direct | 24,996 Reduced 4.41% |
$1,238,552
$49.55 p/Share
|
Mar 18
2014 |
SPB
|
Jefferies Financial Group Inc. |
BUY
Open market or private purchase
|
Indirect | 23,000,000 Added 35.59% |
$253,000,000
$11.0 p/Share
|
Mar 18
2014 |
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Open market or private sale
|
Indirect | 2,446 Reduced 2.16% |
$44,273
$18.1 p/Share
|
Mar 18
2014 |
LOW
|
Ricky D Damron
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 67,949 Reduced 39.64% |
$3,379,783
$49.74 p/Share
|
Mar 18
2014 |
AMT
|
Raymond P Dolan |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 52.47% |
$820,000
$82.0 p/Share
|
Mar 18
2014 |
NCLH
|
Robert Becker
Senior Vice President |
SELL
Open market or private sale
|
Direct | 27,500 Reduced 100.0% |
$878,625
$31.95 p/Share
|
Mar 17
2014 |
URI
|
Jenne K Britell
Director |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 4.03% |
$200,244
$91.02 p/Share
|
Mar 17
2014 |
URI
|
Singleton B Mcallister
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 12.78% |
$275,370
$91.79 p/Share
|
Mar 17
2014 |
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 60,128 Added 0.17% |
$19,757,459
$328.59 p/Share
|
Mar 17
2014 |
V
|
Alfred F Kelly Jr
EXECUTIVE CHAIRMAN |
BUY
Open market or private purchase
|
Direct | 1,575 Added 50.0% |
$350,752
$222.7 p/Share
|
Mar 17
2014 |
ORCL
|
Hector Garcia Molina
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 33.33% |
$94,600
$37.84 p/Share
|
Mar 17
2014 |
NEE
|
William L Yeager
EVP Eng, Const. & ISC |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 31.6% |
$379,360
$94.84 p/Share
|
Mar 17
2014 |
LOW
|
Robert A Niblock
Chairman President & CEO |
SELL
Open market or private sale
|
Direct | 55,576 Reduced 8.93% |
$2,755,458
$49.58 p/Share
|
Mar 17
2014 |
URI
|
Dale A Asplund
EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 15.58% |
$546,000
$91.0 p/Share
|
Mar 14
2014 |
COST
|
John D Mc Kay
Executive Vice President |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 4.35% |
$342,000
$114.0 p/Share
|
Mar 14
2014 |
JNJ
|
Peter Fasolo
Exec VP, Chief HR Officer |
SELL
Open market or private sale
|
Direct | 6,824 Reduced 30.37% |
$635,656
$93.15 p/Share
|
Mar 14
2014 |
COST
|
Richard A Galanti
Executive Vice President |
SELL
Open market or private sale
|
Direct | 15,164 Reduced 23.21% |
$1,738,553
$114.65 p/Share
|
Mar 14
2014 |